ConductScience.org, home

Paper2803071

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Krupp LB and 3 others. Arch Neurol, 1989. Cited by 4,925 papers, by iCite.

Cite this record

ConductScience Library. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Papers, record 2803071. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2803071

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.
PubMed
Journal
Arch Neurol
PubMed
Year
1989
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
4,925
iCite
Relative citation ratio, by iCite
195
iCite
Revised in PubMed
2022-04-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krupp LBL B
2LaRocca NGN G
3Muir-Nash JJ
4Steinberg ADA D

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FatigueMajor topic
Lupus Erythematosus, SystemicMajor topic
Multiple SclerosisMajor topic
Severity of Illness IndexMajor topic
Adult
Disability Evaluation
Humans
Neurologic Examination

Source PubMed

Download CSV of topics

Trials44

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00689793Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood DonorsBackgroundClinicalTrials.gov
NCT01785485IMPACT - Integrative Medicine PrimAry Care TrialBackgroundClinicalTrials.gov
NCT02281513Activity and Nutrition Trial in Lupus to Energize and RenewBackgroundClinicalTrials.gov
NCT02653287Lupus Intervention for Fatigue TrialBackgroundClinicalTrials.gov
NCT02937012Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-respondersResultsClinicalTrials.gov
NCT03070730Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And AntagonistBackgroundClinicalTrials.gov
NCT03446807Safety and Efficacy of Droxidopa for Fatigue in Patients With ParkinsonismBackgroundClinicalTrials.gov
NCT03621761Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis FatigueBackgroundClinicalTrials.gov
NCT03825770Pilot Study of an Educational Program for Adults on Hemodialysis With FatigueBackgroundClinicalTrials.gov
NCT04137809TREAT Foot Drop After Stroke With Ankle RobotBackgroundClinicalTrials.gov
NCT04267107Managing Fatigue in People With Parkinson's DiseaseBackgroundClinicalTrials.gov
NCT04592354Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 SurvivorsBackgroundClinicalTrials.gov
NCT04660227Exercise Training in Pediatric-Onset Multiple Sclerosis PatientsBackgroundClinicalTrials.gov
NCT04673045Effects of Neuromuscular Electrical Stimulation on Individuals With Chronic Stroke in Patients With Chronic StrokeBackgroundClinicalTrials.gov
NCT04733456Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) PatientsBackgroundClinicalTrials.gov
NCT04780828Investigation of the Effects of Different Levels of Obesity on the Respiratory SystemBackgroundClinicalTrials.gov
NCT04827550Fatigue Levels in Fibromyalgia SyndromeBackgroundClinicalTrials.gov
NCT04895371Tele-Physiotherapy After COVID-19 HospitalizationBackgroundClinicalTrials.gov
NCT05012826Osteopathy and Physiotherapy Compared to Physiotherapy Alone on Fatigue and Functional Status in Long COVIDBackgroundClinicalTrials.gov
NCT05319093Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis PatientsBackgroundClinicalTrials.gov

See all 44 trialsDownload CSV of trials

Cited by2,437

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,925 citations.

PMIDTitleJournalYearIn PapersSource
42971600Pulmonary function, functional capacity and physical activity in patients with SLE: a cross-sectional study.Lupus Sci Med2026https://conductscience.org/library/papers/42971600PubMed
42968108STABILOOP, a cohort trial to assess automated insulin delivery in the management of patients living with type 1 diabetes who are eligible for islet transplantation.Trials2026https://conductscience.org/library/papers/42968108PubMed
42959851Rationale and design of RECOVER - a prospective, longitudinal cardiac rehabilitation registry.Am Heart J Plus2026https://conductscience.org/library/papers/42959851PubMed
42955555Concepts and Assessment of Fatigue in Myasthenia Gravis: A Scoping Review.Neurol Ther2026https://conductscience.org/library/papers/42955555PubMed
42953804Symptoms as Correlates of Health-Related Quality of Life in Black and White Individuals With Multiple Sclerosis.Int J MS Care2026https://conductscience.org/library/papers/42953804PubMed
42953443Feasibility, Acceptability, and Initial Efficacy of a Wheelchair Exercise Training Program in People With Multiple Sclerosis.Int J MS Care2026https://conductscience.org/library/papers/42953443PubMed
42952477Effect of mindfulness breathing versus acupoint stimulation on anxiety, fatigue, and sleep quality among children undergoing stem cell transplantation: a three-arm randomized controlled trial.Front Med (Lausanne)2026https://conductscience.org/library/papers/42952477PubMed
42945894Associations between salivary HHV-6 and long COVID severity in a cross-sectional, case-control analysis.EBioMedicine2026https://conductscience.org/library/papers/42945894PubMed
42942946Effects of Oral L-Arginine on Everyday Persistent Fatigue, Sleep, and Post-Exercise Lactate Recovery in Community-Dwelling Working-Age Adults: A Double-Blind, Placebo-Controlled Randomized Trial.Nutrients2026https://conductscience.org/library/papers/42942946PubMed
42940582Problematic Social Media Use and Insomnia Severity Among Saudi University Students: Cross-Sectional Indirect-Association Analyses Involving Fatigue and Anxiety.Healthcare (Basel)2026https://conductscience.org/library/papers/42940582PubMed
42931152Subjective Sleep Quality in Relation to Relapse Status in Relapsing-Remitting Multiple Sclerosis: A Propensity Score-Matched Nested Case-Control Analysis.Neurol Int2026https://conductscience.org/library/papers/42931152PubMed
42929191Continuous Subcutaneous Foslevodopa/Foscarbidopa Improves Nonmotor Symptoms and Fluctuations in Parkinson's Disease.Eur J Neurol2026https://conductscience.org/library/papers/42929191PubMed
42924310Fatigue, anthropometric profile, and health-related quality of life among fifth-year medical students: A single-center cross-sectional study from Kazakhstan.J Educ Health Promot2026https://conductscience.org/library/papers/42924310PubMed
42921597"There's No Magic Pill": A Multimethods Qualitative Study Exploring Routine Fatigue Care in People With Multiple Sclerosis.Int J MS Care2025https://conductscience.org/library/papers/42921597PubMed
42918252Physical and psychological burden in RRMS: depression and fatigue beyond disease duration.Arq Neuropsiquiatr2026https://conductscience.org/library/papers/42918252PubMed
42906448Morning lighting intervention reduces fatigue and improves sleep in Parkinson disease.Neurotherapeutics2026https://conductscience.org/library/papers/42906448PubMed
42903451Intra-operative oxygen concentration could affect postoperative morbidity-results of a randomised controlled feasibility trial (PULSE Ox).Anaesth Rep2026https://conductscience.org/library/papers/42903451PubMed
42903028Feasibility of Aerobic Exercise in People With Advanced Multiple Sclerosis: Characterizing Acute Responses to Inform Exercise Prescription.Int J MS Care2025https://conductscience.org/library/papers/42903028PubMed
42903011Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After Intervention.Int J MS Care2025https://conductscience.org/library/papers/42903011PubMed
42898520Latent classes and symptom network analysis of kinesiophobia in older adult patients with chronic obstructive pulmonary disease.Front Med (Lausanne)2026https://conductscience.org/library/papers/42898520PubMed

See all 2,437 cited byDownload CSV of cited by

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
URSODIOLCHEMBL1551Results1https://conductscience.org/library/drugs/CHEMBL1551ChEMBL
BEZAFIBRATECHEMBL264374Results1https://conductscience.org/library/drugs/CHEMBL264374ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2803071

GET https://conductscience.org/api/papers/v1/2803071/trials?page=2